Hester Biosciences Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jul '26 Jul 22, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Market Capitalization	20,665	10,741	10,667	11,818	12,934	23,099
Market Cap Growth	28.72%	0.70%	-9.74%	-8.63%	-44.00%	41.66%
Enterprise Value	22,623	12,929	13,063	14,503	15,490	24,167
Last Close Price	2431.00	1253.66	1244.76	1380.29	1500.38	2661.63
PE Ratio	37.14	19.31	38.81	62.57	48.58	58.75
PS Ratio	6.18	3.22	3.41	3.80	4.65	9.37
PB Ratio	5.62	2.92	3.27	3.90	4.48	8.64
P/TBV Ratio	5.90	3.06	3.47	4.11	4.67	8.96
P/FCF Ratio	44.62	23.19	24.29	49.69	-	-
P/OCF Ratio	32.22	16.75	16.54	24.53	54.82	265.14
EV/Sales Ratio	6.77	3.87	4.18	4.66	5.57	9.80
EV/EBITDA Ratio	23.98	15.83	23.22	24.17	24.81	33.90
EV/EBIT Ratio	29.90	18.66	28.63	33.63	36.86	43.91
EV/FCF Ratio	48.85	27.92	29.74	60.97	-	-
Debt / Equity Ratio	0.53	0.53	0.65	0.85	0.95	0.85
Debt / EBITDA Ratio	2.21	2.21	3.43	4.28	4.38	3.19
Debt / FCF Ratio	4.21	4.21	4.86	10.84	-	-
Net Debt / Equity Ratio	0.51	0.51	0.63	0.80	0.90	0.76
Net Debt / EBITDA Ratio	2.31	2.31	3.66	4.04	4.16	2.85
Net Debt / FCF Ratio	4.07	4.07	4.69	10.19	-4.79	-2.33
Asset Turnover	0.50	0.50	0.48	0.47	0.45	0.51
Inventory Turnover	1.23	1.23	1.27	1.24	1.03	0.99
Quick Ratio	0.72	0.72	0.70	0.95	0.68	0.85
Current Ratio	1.37	1.37	1.56	2.04	1.53	2.01
Return on Equity (ROE)	16.55%	16.55%	9.16%	7.16%	10.09%	15.69%
Return on Assets (ROA)	6.51%	6.51%	4.33%	4.05%	4.26%	7.07%
Return on Invested Capital (ROIC)	9.44%	9.65%	6.17%	5.23%	5.76%	10.22%
Return on Capital Employed (ROCE)	13.20%	13.20%	8.60%	7.70%	8.10%	11.80%
Earnings Yield	2.69%	5.18%	2.58%	1.60%	2.06%	1.70%
FCF Yield	2.24%	4.31%	4.12%	2.01%	-4.19%	-3.77%
Dividend Yield	0.46%	0.88%	0.56%	0.43%	0.53%	0.38%
Payout Ratio	10.83%	10.83%	18.80%	36.28%	31.95%	21.63%
Total Shareholder Return	0.46%	0.88%	0.56%	0.43%	0.53%	0.38%